KR20240159657A - Vvn001을 함유하는 안과 조성물 - Google Patents

Vvn001을 함유하는 안과 조성물 Download PDF

Info

Publication number
KR20240159657A
KR20240159657A KR1020247022421A KR20247022421A KR20240159657A KR 20240159657 A KR20240159657 A KR 20240159657A KR 1020247022421 A KR1020247022421 A KR 1020247022421A KR 20247022421 A KR20247022421 A KR 20247022421A KR 20240159657 A KR20240159657 A KR 20240159657A
Authority
KR
South Korea
Prior art keywords
acid
ophthalmic composition
sodium
ophthalmic
vvn001
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247022421A
Other languages
English (en)
Korean (ko)
Inventor
얼닝 시아
치아오 한
왕 센
양칭친 루
홍얀 가오
Original Assignee
비바비젼 바이오테크 엘티디
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 비바비젼 바이오테크 엘티디 filed Critical 비바비젼 바이오테크 엘티디
Publication of KR20240159657A publication Critical patent/KR20240159657A/ko
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020247022421A 2023-04-27 2023-05-25 Vvn001을 함유하는 안과 조성물 Pending KR20240159657A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202310476403.2A CN118892446A (zh) 2023-04-27 2023-04-27 一种含vvn001的眼科组合物
CN202310476403.2 2023-04-27
PCT/CN2023/096273 WO2024221527A1 (zh) 2023-04-27 2023-05-25 一种含vvn001的眼科组合物

Publications (1)

Publication Number Publication Date
KR20240159657A true KR20240159657A (ko) 2024-11-05

Family

ID=93255459

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247022421A Pending KR20240159657A (ko) 2023-04-27 2023-05-25 Vvn001을 함유하는 안과 조성물

Country Status (9)

Country Link
EP (1) EP4702974A1 (https=)
JP (1) JP2025516407A (https=)
KR (1) KR20240159657A (https=)
CN (1) CN118892446A (https=)
AU (1) AU2023361985B2 (https=)
CA (1) CA3238321A1 (https=)
IL (1) IL312531A (https=)
TW (1) TW202442220A (https=)
WO (1) WO2024221527A1 (https=)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0589020A4 (en) * 1992-03-18 1994-07-06 Coopervision Pharma Verapamil hcl formulation and other ophthalmic solutions with buffer system for ocular administration
US5800807A (en) * 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
HUE059052T2 (hu) * 2014-11-07 2022-10-28 Santen Pharmaceutical Co Ltd Vizes szemészeti készítmény
WO2019001171A1 (zh) * 2017-06-27 2019-01-03 维眸生物科技上海有限公司 一种含磷化合物及其制备和应用
CN109134533B (zh) * 2017-06-27 2020-08-11 维眸生物科技（上海）有限公司 一种含磷化合物及其制备和应用
CN114533652B (zh) * 2018-09-25 2024-12-13 沈阳兴齐眼药股份有限公司 药物组合物、其制备方法和用途
US20230172946A1 (en) * 2019-08-18 2023-06-08 Iview Therapeutics, Inc. In-situ Gel Forming Ophthalmic Formulations Containing Difluprednate
IT202000027155A1 (it) * 2020-11-12 2022-05-12 Sifi Spa Formulazione a base di poliesametilene biguanide per il trattamento della cheratite da acanthamoeba
PL4312986T3 (pl) * 2021-04-01 2025-02-17 Active Biotech Ab Preparat lakwinimodu do stosowania do oczu

Also Published As

Publication number Publication date
TW202442220A (zh) 2024-11-01
EP4702974A1 (en) 2026-03-04
JP2025516407A (ja) 2025-05-30
CN118892446A (zh) 2024-11-05
AU2023361985A1 (en) 2024-11-14
CA3238321A1 (en) 2025-07-08
AU2023361985B2 (en) 2025-08-14
IL312531A (en) 2024-11-01
WO2024221527A1 (zh) 2024-10-31

Similar Documents

Publication Publication Date Title
US11701343B2 (en) Compositions and methods for treating ocular disorders
WO2020178429A1 (en) Ophthalmic composition for treating dry eye and symptoms thereof
JP2018177820A (ja) 水性眼科組成物
MD3718535T2 (ro) Compoziții oftalmice care conţin o prostamidă care eliberează oxid nitric
BG99483A (bg) Офталмологичен препарат
JP6473274B1 (ja) 熱ゲル化人工涙液
KR20240159657A (ko) Vvn001을 함유하는 안과 조성물
JP2025516407A5 (https=)
HK40113077A (zh) 一种含vvn001的眼科组合物
KR20240032950A (ko) 록소프로펜나트륨을 함유하는 조성물
US20260060973A1 (en) Ophthalmic Composition for Treating Non-Infectious Inflammatory Diseases
EP4454639A1 (en) Ophthalmic composition comprising carbomer and taurine
TW202442233A (zh) 一種用於治療非感染性炎症疾病的眼科組合物
WO2024034592A1 (ja) Ｕｄｃａまたはその塩を含有する水性医薬組成物
HK40113256A (zh) 一种用於治疗非感染性炎症疾病的眼科组合物
RU2443416C2 (ru) Капли глазные
CZ13722U1 (cs) Oční instilace se zlepšenou stabilitou účinné látky na bázi brimonidinu

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20240704

Patent event code: PA01051R01D

Comment text: International Patent Application

PA0201 Request for examination
PG1501 Laying open of application